Abstracts (PDF file, 1.8MB) - Society for Risk Analysis
Abstracts (PDF file, 1.8MB) - Society for Risk Analysis
Abstracts (PDF file, 1.8MB) - Society for Risk Analysis
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
SRA 2013 Annual Meeting <strong>Abstracts</strong><br />
W3-B.4 Clewell, III, HJ*; Andersen, M; Gentry, PR; The<br />
Hamner Institutes <strong>for</strong> Health Sciences, ENVIRON International<br />
Corporation; hclewell@thehamner.org<br />
Pharmacokinetics of <strong>for</strong>maldehyde and the impact of<br />
endogenous levels on uptake<br />
Formaldehyde is present endogenously, with measurable<br />
concentrations in the tissues and exhaled breath of humans.<br />
While <strong>for</strong>maldehyde is highly water soluble and readily<br />
absorbed in the respiratory tract, there is little evidence of<br />
systemic delivery. The presence of endogenous concentrations<br />
of <strong>for</strong>maldehyde adds complexity to understanding the<br />
contribution of exogenous exposure to target tissue<br />
concentrations that may result in adverse effects.<br />
Computational Fluid Dynamic (CFD) modeling has been<br />
conducted to investigate the impact of the presence of<br />
endogenous <strong>for</strong>maldehyde on the absorption of exogenous<br />
<strong>for</strong>maldehyde from the nasal cavity of rats, monkeys, and<br />
humans. Based on the CFD modeling, exogenous exposure to<br />
concentrations below 0.2 ppm via inhalation are not expected to<br />
cause increases in tissue concentrations above background,<br />
even at the site of contact. At high exposure concentrations,<br />
<strong>for</strong>maldehyde concentrations are much greater in the air than<br />
in the tissue, which leads to rapid absorption in the anterior<br />
nasal passages due to the high rate of <strong>for</strong>maldehyde<br />
partitioning into nasal tissues. At low exposure concentrations,<br />
however, the concentration gradient between air and tissue is<br />
greatly reduced due to the presence of endogenous<br />
<strong>for</strong>maldehyde in nasal tissues, leading to reduced tissue dose.<br />
Biologically-based dose-response models have previously been<br />
developed to characterize both the toxicokinetics and<br />
toxicodynamics of <strong>for</strong>maldehyde in the rat and human;<br />
however, these models do not consider endogenous production<br />
of <strong>for</strong>maldehyde and thus the results at low concentrations may<br />
be questionable. Newer PK models can now track cellular<br />
<strong>for</strong>maldehyde and differential <strong>for</strong>mation of DNA-adducts from<br />
both endogenous and exogenous <strong>for</strong>maldehyde. These results<br />
suggest that understanding endogenous concentrations of a<br />
compound such as <strong>for</strong>maldehyde are of critical importance in<br />
characterizing the shape of the dose response curve in the low<br />
dose region <strong>for</strong> risk assessment.<br />
W4-J.1 Coglianese, C; University of Pennsylvania;<br />
cary_coglianese@law.upenn.edu<br />
Moving Forward in Looking Back: How to Improve<br />
Retrospective Regulatory Review<br />
Since 1982, the U.S. federal government has implemented an<br />
extensive regulatory review process that considers the costs<br />
and benefits of proposed regulations -- be<strong>for</strong>e they are adopted.<br />
By contrast, the federal government has little by way of<br />
institutionalized review of regulations' costs and benefits after<br />
they have been adopted. The Obama Administration -- like<br />
several earlier administrations -- has adopted an ad hoc<br />
retrospective review of existing regulations, or what it calls<br />
"regulatory look-back." This paper assesses the Obama<br />
regulatory look-back initiative, e.g., what it has undertaken and<br />
accomplished, but also analyzes additional steps that could be<br />
taken to improve, and even institutionalize, the practice of<br />
retrospectively evaluating existing risk regulations.<br />
T3-J.1 Coglianese, C*; Carrigan, C; University of Pennsylvania;<br />
cary_coglianese@law.upenn.edu<br />
Why Politicians Think Regulation Kills Jobs...When<br />
Economists Don't<br />
This paper juxtaposes the intense political controversy over the<br />
connection between jobs and regulation with the rather benign<br />
findings of the economics literature. For many politicians,<br />
regulations are "job-killers," while most of the economic<br />
research suggests that regulation yields no substantial net<br />
change in employment. This paper analyzes and explains the<br />
disjunction, showing that politicians respond to the distribution<br />
of job impacts while economists consider aggregate effects.<br />
While <strong>for</strong> many years, the impact analyses that accompanied<br />
new regulatory proposals contained little attention to<br />
employment effects, this has been because the economists' view<br />
prevailed. Since the 2008 recession, however, the political<br />
process has demanded more explicit focus on job impacts. This<br />
paper considers the rationale <strong>for</strong> job impact analysis of new risk<br />
regulations from the standpoint of democratic theory.<br />
T1-B.2 Cogliano, V; US Government; cogliano.vincent@epa.gov<br />
Enhancing IRIS: Progress to Date and Future Actions<br />
EPA has made numerous enhancements to its Integrated <strong>Risk</strong><br />
In<strong>for</strong>mation System (IRIS) program, which evaluates scientific<br />
in<strong>for</strong>mation on health effects that may result from exposure to<br />
environmental contaminants. These enhancements are intended<br />
(1) to improve the fundamental science of IRIS assessments, (2)<br />
to improve the productivity of the program, and (3) to increase<br />
transparency so issues are identified and debated early. The<br />
IRIS program has also enacted measures to ensure that the<br />
assessments it undertakes will be important to public health<br />
and to EPA’s priorities. As part of improving the fundamental<br />
science of IRIS assessments, the IRIS program is adopting<br />
principles of systematic review in all its new assessments. An<br />
expanded section on hazard identification will identify all health<br />
hazards where there is credible evidence of an effect.<br />
Assessments will include toxicity values <strong>for</strong> multiple health<br />
effects, increasing their utility in subsequent risk analyses and<br />
decisions. Be<strong>for</strong>e work on an assessment begins, conversations<br />
with EPA’s program and regional offices will ensure that IRIS<br />
assessments meet their varied needs, and input from external<br />
stakeholders will help in <strong>for</strong>mulating the problems to be<br />
addressed in the assessment. Improved science, improved<br />
productivity, and improved transparency – these will be evident<br />
in the new, enhanced IRIS program. The views expressed in<br />
this abstract do not necessarily represent the views or policies<br />
of the U.S. Environmental Protection Agency.<br />
December 8-11, 2013 - Baltimore, MD